Posts tagged with "Senator Ron Johnson (R-Wisconsin)"

Turning tail: Senate Republicans warn White House against Mexico tariffs

June 6, 2019

Et tu, GOP? Even the Senate Republican are starting to doubt the wisdom of Trump’s tariffs—especially those he means to impose against Mexico. After all, Americans like their avocados, tequila, and automobiles.

Indeed, according to a New York Times report, Republican senators sent the White House a clear and compelling message on June 4—warning that they were almost unanimously opposed to the president’s plans to establish tariffs on Mexican imports, just hours after the president said lawmakers would be “foolish” to try to stop him.

The administration’s latest move to intimidate the nation’s southern neighbor in the face of rising illegal immigration at the border will create a “tax” against Americans, the GOP claims (and Democrats agree). Trump has threatened to set 5% tariffs on all goods imported from Mexico, rising to as high as 25%, until the Mexican government stems the flow of migrants, the Times said.

Republican senators emerged from a closed-door lunch at the Capitol angered by the briefing they received from a deputy White House counsel and an assistant attorney general on the legal basis for the president to impose new tariffs by declaring a national emergency at the southern border.

“I want you to take a message back” to the White House, Senator Ted Cruz (R-Texas), told the lawyers, according to Times sources. Cruz warned that “you didn’t hear a single yes” from the Republican conference. He called the proposed tariffs a $30 billion tax increase on Texans.

“I will yield to nobody in passion and seriousness and commitment for securing the border,” Mr. Cruz later told reporters. “But there’s no reason for Texas farmers and ranchers and manufacturers and small businesses to pay the price of massive new taxes.”

Texas would be hit the hardest by the proposed tariffs on Mexican products, followed by Michigan, California, Illinois and Ohio, according to the U.S. Chamber of Commerce. A 25% tariff would threaten $26.75 billion of Texas imports.

In fact, the Chamber notes on its home page, “Imposing tariffs on Mexico is exactly the wrong move. These tariffs will be paid by American families and businesses without doing a thing to solve the very real problems at he border.

“We’re holding a gun to our own heads,” said Senator John Cornyn, (R-Texas).

If Mr. Trump were to declare an emergency to impose the tariffs, the House and the Senate could pass a resolution disapproving them. But such a resolution would almost certainly face a presidential veto, meaning that both the House and the Senate would have to muster two-thirds majorities to beat Mr. Trump.

Senator Ron Johnson (R-Wisconsin) said he warned the lawyers  during the closed-door meeting that the Senate could muster an overwhelming majority to beat back the tariffs, even if the president were to veto a resolution disapproving them. Republicans may be broadly supportive of Trump’s push to build a wall and secure the border, he said, but they oppose tying immigration policy to the imposition of tariffs on Mexico.

“The White House should be concerned about what that vote would result in, because Republicans really don’t like taxing American consumers and businesses,” Senator Johnson said.

However, the Times reported, when asked about Senate Republicans discussing ways to block the tariffs during his UK trip, President Trump responded, “I don’t think they will do that. I think if they do, it’s foolish.”

Research contact: @maggieNYT

‘Right to Try’ bill heads to White House for signature

May 31, 2018

Nearly 90% of Americans want the chance to try experimental drugs when they are critically ill and “have everything to gain and nothing to lose,” based on findings of a poll conducted in March by CancerHealth.com.

They (and their families and friends) are celebrating the passage of Right to Try legislation by the U.S. House of Representatives—successfully culminating a multi-year campaign by the Goldwater Institute to give such patients access to drugs not yet approved by the Food and Drug Administration (FDA). Specifically, the bill gives terminally ill patients the right to seek drug treatments that remain in clinical trials and “have passed Phase 1 of the Food and Drug Administration’s approval process,” but have not been fully approved by the agency.

The House passed the bill, sponsored by Senator Ron Johnson (R-Wisconsin), on May 29 by a vote of 250 to 169, sending it on to President Donald Trump’s desk for signature. According to coverage by Biopharma Dive, the act covers a much broader population than an earlier House-passed version. The president has been a vocal advocate despite warnings from patient groups and top FDA staffers including Commissioner Scott Gottlieb that it may have unintended effects and potentially hinder FDA’s authority .

On the other hand, Biopharma Dive reported, conservative groups—including Freedom Partners and Americans for Prosperity—backed the effort; calling attention to the fact that 40 states have passed versions of the bill.

“The Administration believes that these patients and their families should be able to seek access to potentially life-saving therapies while those treatments are still under review by the FDA,” an administration policy statement said.

The legislation passed via unanimous consent in the Senate last August.

In a May 21 letter, more than 100 patient advocacy groups—among them, The American Cancer Society, the Alliance of Dedicated Cancer Centers, the Cancer Action Network, Friends of Cancer Research and the National Organization for Rare Disorders—urged House Speaker Paul Ryan (R-Wisconsin) and Minority Leader Nancy Pelosi (D-California) to reject the bill. The groups argued that. while they did not support the previous House-passed bill either, at least it had comprised several safeguards that are missing from the new legislation.

Senior House GOP leadership praised the bill as a leap forward for patients.

Research contact: @SGottliebFDA